DNTH vs ICE · rev $6.2M vs P/E 37, rev $12.64B
Dianthus Therapeutics Inc. (DNTH) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
DNTH currently screens at market cap $4.40B. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the DNTH and ICE stock pages for the full models.
Not investment advice.